Gene · 49
Papers2,647
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,647
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TIRADS Management Guidelines in the Investigation of Thyroid Nodules; Illustrating the Concerns, Costs, and Performance. | J Endocr Soc | 2020 | 32285020 | PubTator, text mining | PubMed |
| Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population: a cross-sectional survey. | BMC Nephrol | 2020 | 32245423 | PubTator, text mining | PubMed |
| Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis. | Rheumatology (Oxford) | 2020 | 32240313 | PubTator, text mining | PubMed |
| Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study. | Sci Rep | 2020 | 32238873 | PubTator, text mining | PubMed |
| The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review. | Clin Pharmacol Ther | 2020 | 32236956 | PubTator, text mining | PubMed |
| Reactive Oxygen Species and Male Fertility. | Antioxidants (Basel) | 2020 | 32235383 | PubTator, text mining | PubMed |
| Systemic Lupus Erythematosus with Multiple Autoimmune Disease Presented with Extensive Peripheral Gangrene. | Case Rep Rheumatol | 2020 | 32231842 | PubTator, text mining | PubMed |
| Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis. | Arthritis Res Ther | 2020 | 32216829 | PubTator, text mining | PubMed |
| Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease. | Int J Mol Sci | 2020 | 32183005 | PubTator, text mining | PubMed |
| Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials. | Rheumatology (Oxford) | 2020 | 32182362 | PubTator, text mining | PubMed |
| American College of Radiology Thyroid Imaging Reporting and Data System standardises reporting of thyroid ultrasounds. | SA J Radiol | 2020 | 32161675 | PubTator, text mining | PubMed |
| Treatment guidelines in psoriatic arthritis. | Rheumatology (Oxford) | 2020 | 32159790 | PubTator, text mining | PubMed |
| Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes. | Proc Natl Acad Sci U S A | 2020 | 32156733 | PubTator, text mining | PubMed |
| A Simple Equation to Estimate Urinary Flow Rate Using Urine Creatinine. | Am J Nephrol | 2020 | 32150743 | PubTator, text mining | PubMed |
| Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels. | Clin Exp Rheumatol | 2020 | 32141436 | PubTator, text mining | PubMed |
| Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility. | Int J Mol Sci | 2020 | 32138324 | PubTator, text mining | PubMed |
| Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis. | Arthritis Rheumatol | 2020 | 32134199 | PubTator, text mining | PubMed |
| Proteomic Analyses of Human Sperm Cells: Understanding the Role of Proteins and Molecular Pathways Affecting Male Reproductive Health. | Int J Mol Sci | 2020 | 32120839 | PubTator, text mining | PubMed |
| Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides. | Genome Biol | 2020 | 32102684 | PubTator, text mining | PubMed |
| Combined Aerobic and Resistance Exercise Training Reduces Circulating Apolipoprotein J Levels and Improves Insulin Resistance in Postmenopausal Diabetic Women. | Diabetes Metab J | 2020 | 32097999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/papers?page=51